At a glance
ClinicalIndex Comparison RecordN/ACompleted· 58 enrolled
Drug / intervention
Twice Weekly Hemodialysis then Thrice Weekly Hemodialysis +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of Twice Weekly Hemodialysis in Patients With Residual Kidney Function
In Brief
A clinical study evaluating Twice Weekly Hemodialysis then Thrice Weekly Hemodialysis and Thrice Weekly Hemodialysis then Twice Weekly Hemodialysis for Hemodialysis and Kidney Failure, Chronic. Completed, enrolled 58 participants across 3 sites.
Detailed Summary
The study will determine the efficacy of twice weekly hemodialysis in patients with residual kidney function.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHemodialysis, Kidney Failure, Chronic
CountriesUnited States
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartJul 2018
First PostedMar 2019
Primary CompletionSep 2024
Study CompletionMay 2025
TodayJul 2026
First PostedMar 14, 2019
Enrollment StartJul 1, 2018
Primary CompletionSep 1, 2024
Study CompletionMay 31, 2025
TodayJul 2, 2026
Enrollment to primary: 6.2 yearsPosted 7.3 years ago
Interventions
Twice Weekly Hemodialysis then Thrice Weekly Hemodialysisother
Twice weekly hemodialysis for 4 weeks, then thrice weekly hemodialysis for 4 weeks.
Thrice Weekly Hemodialysis then Twice Weekly Hemodialysisother
Thrice weekly hemodialysis for 4 weeks, then twice weekly hemodialysis for 4 weeks.